Claiborne Cary J

CIK 00013709305 companiesHERZLIYA

SEC Profile

Transactions

Companies

Filings

CIK

0001370930

Recent Transactions

50 trades

Award
ADIAL PHARMACEUTICALS, INC.$ADIL
Stock Option (Right to Buy)
2025-05-29+138,000→ 138,000 total
Award
ADIAL PHARMACEUTICALS, INC.$ADIL
Stock Option (Right to Buy)
2024-12-05+350,000→ 350,000 total
Award
ADIAL PHARMACEUTICALS, INC.$ADIL
Stock Option (Right to Buy)
2024-03-25+60,000→ 60,000 total
Award
LadRx Corp$LADX
Stock Option (Right to Buy)
2024-01-15+5,000→ 5,000 total
Award
ADIAL PHARMACEUTICALS, INC.$ADIL
Stock Option (Right to Buy)
2023-05-23+300,000→ 300,000 total
Award
ADIAL PHARMACEUTICALS, INC.$ADIL
Common Stock
2023-05-23+420,000→ 1,520,000 total
Award
ADIAL PHARMACEUTICALS, INC.$ADIL
Common Stock
2022-09-20$0.42/sh+75,000→ 1,100,000 total
Award
ADIAL PHARMACEUTICALS, INC.$ADIL
Common Stock
2022-09-19$0.43/sh+25,000→ 1,025,000 total
Award
ADIAL PHARMACEUTICALS, INC.$ADIL
Common Stock
2022-08-18+1,000,000→ 1,000,000 total
Award
ADIAL PHARMACEUTICALS, INC.$ADIL
Employee Stock Option
2022-02-23+6,667→ 6,667 total
Award
ADIAL PHARMACEUTICALS, INC.$ADIL
Stock options
2021-12-07+130,000→ 130,000 total
Award
ADIAL PHARMACEUTICALS, INC.$ADIL
Stock Option
2021-11-02+60,000→ 60,000 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2014-12-16$4.07/sh+42,900→ 45,764 total
Sale
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2014-12-16$12.91/sh−42,900→ 2,864 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2014-12-16−42,900→ 99,987 total
Sale
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2014-12-15$12.89/sh−7,100→ 2,864 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2014-12-15−7,100→ 142,887 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2014-12-15$4.07/sh+7,100→ 9,964 total
Award
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
2014-09-11+22,027→ 124,987 total
Award
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
2014-09-11+25,000→ 149,987 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock (ESPP)
2014-06-30$6.56/sh+267→ 2,621 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock (ESPP)
2014-03-31$6.79/sh+220→ 2,354 total
Sale
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2014-02-27$9.00/sh−2,390→ 110 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2014-02-27−2,500→ 102,960 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2014-02-27$4.07/sh+2,500→ 2,500 total
Sale
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2014-02-27$9.06/sh−110→ 0 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2014-01-07−2,400→ 105,560 total
Sale
Sucampo Pharmaceuticals, Inc.
Common Stock
2014-01-07$9.00/sh−2,500→ 0 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Common Stock
2014-01-07$4.41/sh+2,400→ 2,400 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Common Stock
2014-01-07$4.07/sh+100→ 2,500 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2014-01-07−100→ 105,460 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock (ESPP)
2013-12-31$8.93/sh+196→ 2,134 total
Exercise of In-Money
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2013-11-25$7.64/sh−12,989→ 109,898 total
Exercise of In-Money
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
2013-11-25$7.64/sh−12,940→ 109,947 total
Exercise of In-Money
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
2013-11-25$7.64/sh−49→ 109,898 total
Exercise of In-Money
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2013-11-22$7.46/sh−3,511→ 122,887 total
Exercise of In-Money
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
2013-11-22$7.46/sh−3,511→ 122,887 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock (ESPP)
2013-09-30$5.93/sh+253→ 1,938 total
Award
Sucampo Pharmaceuticals, Inc.
Class A Common Stock (ESPP)
2013-06-28$6.25/sh+280→ 1,685 total
Exercise of In-Money
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
2013-05-24$9.00/sh−2,000→ 125,865 total
Exercise of In-Money
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2013-05-24$9.00/sh−10,300→ 125,865 total
Exercise of In-Money
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
2013-05-24$9.00/sh−8,300→ 127,865 total
Sale
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2013-05-21$9.55/sh−2,400→ 136,165 total
Sale
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2013-05-20$9.50/sh−2,240→ 138,565 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock (ESPP)
2013-03-28$6.21/sh+242→ 1,405 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock (ESPP)
2012-12-31$4.66/sh+376→ 1,163 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock (ESPP)
2012-09-28$4.78/sh+313→ 787 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock (ESPP)
2012-06-29$6.68/sh+263→ 474 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock (ESPP)
2012-03-30$7.08/sh+211→ 211 total
Award
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (Right to buy)
2011-10-17+77,640→ 77,640 total

Companies

Recent Filings

Address

C/O NEUROSENSE THERAPEUTICS LTD. 11 HAMENOFIM STREET, BUILDING B

HERZLIYA, 4672562

View on SEC.gov